Omnicell delivers strong fourth quarter financial results. Results exceed previously issued full year guidance for bookings, total revenues, and non-GAAP EBITDA. FORT WORTH, Texas ...

On a per-share basis, the Fort Worth, Texas-based company said it had profit of 34 cents. Earnings, adjusted for one-time gains and costs, came to 60 cents per share. The results beat Wall Street ...

Clear Channel Outdoor Holdings, Inc. (the "Company") today announced it has completed the sale of its businesses in Mexico, Peru and Chile to Global Media US LLC, doing business as Global Vía Pública ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...

Broken String Biosciences ("Broken String"), a leader in advancing gene editing safety, today opened its Catalyst Early Access Program (EAP) for developers of gene-edited therapies that allow for the ...

Stereotaxis, Inc. STXS, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, ...

Omnicell anticipates 2025 total revenue to range from $1.105 million to $1.155 million, with product bookings expected between $500 million and $550 million and annual recurring revenue ( ARR) ...

In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Omnicell (OMCL – Research Report). The company’s shares ...

Reports Q4 revenue $307M, consensus $300.01M. “We delivered solid financial results for Q4 2024, including returning to year-over-year revenue ...

The company's bookings for the year ended December 31, 2024, totaled $923 million, showing an increase of 8% year-over-year ...